MRM
Income statement / Annual
Last year (2023), MEDIROM Healthcare Technologies Inc.'s total revenue was $6.83 B,
a decrease of 1.81% from the previous year.
In 2023, MEDIROM Healthcare Technologies Inc.'s net income was $115.05 M.
See MEDIROM Healthcare Technologies Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$6.83 B
|
$6.95 B
|
$5.41 B
|
$3.34 B
|
$3.91 B
|
$3.43 B
|
| Cost of Revenue |
$5.26 B |
$5.05 B |
$3.99 B |
$2.91 B |
$2.96 B |
$2.48 B |
| Gross Profit |
$1.57 B |
$1.90 B |
$1.42 B |
$428.95 M |
$950.76 M |
$956.87 M |
| Gross Profit Ratio |
0.23 |
0.27 |
0.26 |
0.13 |
0.24 |
0.28 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$1.80 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$162.03 M
|
$135.13 M
|
$130.96 M
|
$92.46 M
|
$77.91 M
|
$71.21 M
|
| Selling, General &
Administrative Expenses |
$1.96 B
|
$1.81 B
|
$1.81 B
|
$1.07 B
|
$871.86 M
|
$842.82 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$1.96 B |
$1.72 B |
$1.82 B |
$1.04 B |
$905.21 M |
$850.61 M |
| Cost And Expenses |
$7.22 B |
$6.77 B |
$5.81 B |
$3.96 B |
$3.86 B |
$3.33 B |
| Interest Income |
$1.11 M |
$3.73 M |
$11.11 M |
$11.90 M |
$12.25 M |
$14.70 M |
| Interest Expense |
$36.87 M |
$9.80 M |
$11.95 M |
$13.23 M |
$13.59 M |
$15.49 M |
| Depreciation &
Amortization |
$252.60 M
|
$184.06 M
|
$126.24 M
|
$62.29 M
|
$46.17 M
|
$44.27 M
|
| EBITDA |
$310.09 M
|
$281.02 M
|
-$269.13 M
|
-$577.30 M
|
$125.07 M
|
$158.31 M
|
| EBITDA Ratio |
0.05 |
0.04 |
-0.05 |
-0.17 |
0.03 |
0.05 |
| Operating Income Ratio
|
-0.06
|
0.01
|
-0.07
|
-0.19
|
0.02
|
0.03
|
| Total Other
Income/Expenses Net |
$412.20 M
|
$82.81 M
|
$56.11 M
|
$119.40 M
|
-$1.05 M
|
-$22.48 M
|
| Income Before Tax |
$20.62 M |
$179.77 M |
-$414.48 M |
-$626.69 M |
$33.30 M |
$91.56 M |
| Income Before Tax Ratio
|
0
|
0.03
|
-0.08
|
-0.19
|
0.01
|
0.03
|
| Income Tax Expense |
-$94.43 M |
$30.81 M |
$576.25 M |
$87.52 M |
$15.96 M |
$25.25 M |
| Net Income |
$115.05 M |
$148.97 M |
-$990.73 M |
-$539.17 M |
$17.34 M |
$66.31 M |
| Net Income Ratio |
0.02 |
0.02 |
-0.18 |
-0.16 |
0 |
0.02 |
| EPS |
22.27 |
30.54 |
-203.13 |
-133.97 |
4.63 |
18.06 |
| EPS Diluted |
22.27 |
27.23 |
-203.13 |
-133.97 |
4.06 |
14.04 |
| Weighted Average Shares
Out |
$5.17 M
|
$5.47 M
|
$4.88 M
|
$4.02 M
|
$4.27 M
|
$4.72 M
|
| Weighted Average Shares
Out Diluted |
$5.17 M
|
$5.47 M
|
$4.88 M
|
$4.02 M
|
$4.27 M
|
$4.72 M
|
| Link |
|
|
|
|
|
|
